Laurel Venture Capital acquires Alpine’s GSNOR assets

Laurel Venture Capital has acquired Alpine Immune Sciences‘ S-Nitrosoglutathione Reductase assets. No financial terms were disclosed. Seattle-based Alpine is focused on discovering and developing protein-based immunotherapies to treat cancer, autoimmune/inflammatory illnesses and other diseases.

Vladmir Putin

PE HUB First Read

First Read ends your week with news Domino’s wants to open thousands of stores, President Trump plans on inviting Vladmir Putin to visit Washington, D.C. this fall and tourist boat in Missouri capsizes, killing at least 11.


Thoma Bravo-backed Riskonnect to buy Marsh ClearSight

Riskonnect, a portfolio company of Thoma Bravo, has agreed to acquire Marsh ClearSight LLC, a provider of safety, and claims software and services and a business unit of Marsh. No financial terms were disclosed. The deal is expected to close in the third quarter. Kirkland & Ellis LP advised Thoma Bravo and Riskonnect.


NewSpring invests in Radius

NewSpring has invested in Radius Global Market Research, a New York-based market research firm. Proceeds of the deal were used to acquire Cincinnati-based Illumination Research.


PE-backed Smile Brands buys P3 Dental Group

Smile Brands, which is backed by Gryphon Investors, has acquired Las Vegas-based P3 Dental Group, which currently operates five general dentistry offices and two specialty practices providing implants and endodontic services. No financial terms were disclosed.


Sterling Organization amasses $495 mln for fund

Sterling Organization, a private equity real investment management and services firm, has closed its third value-add retail real estate fund at $495 million, beating its $450 million target. The limited partners of Sterling Value Add Partners III LP include domestic endowments, foundations, private and public pension plans, fund of funds and large family offices. The fund will target grocery-anchored shopping centers, street retail, power centers and mixed-use properties in major markets across the United States.

21st Century Fox

PE HUB Second Opinion

In Second Opinion, Mark Zuckerberg is blasted after saying Holocaust deniers should be able to post on Facebook, President Trump rips the Federal Reserve for raising interest rates and Comcast drops its bid for Fox assets.


Campbell Lutyens promotes six principals

Adviser Campbell Lutyens has promoted six new principals in its London, New York and Hong Kong offices. Among those receiving promotions are Annabelle Judd in London, Ryan Mason in New York and James Shipperlee in Hong Kong.


EisnerAmper launches real estate private equity group

EisnerAmper, an advisory and accounting firm, has formed a real estate private equity group, according to a news announcement on its site. Lisa Knee, a partner at the firm who is based in New York City, will serve as the national leader of the group. Also serving on the leadership team are Todd Hankin, another partner, who will lead the West Coast real estate private equity practice from the firm’s San Francisco office and Maureen Blair, another partner, who is based in New York City, who will lead the East Coast real estate private equity practice.


Valor closes fourth fund at $1.05 bln

Valor Equity Partners has raised $1.05 billion for its fourth fund. The private equity firm mostly invests in the consumer, engineered products and services sectors. Mercury Capital Advisors Group LP was the placement agent while Kirkland and Ellis LLP provided legal advice.


Compass makes three acquisitions from Bridgepoint

Compass Partners has made three acquisitions from Bridgepoint. They are Rodenstock, a German maker of manufacturers of ophthalmic lenses and frames; Infinitas Learning, a Dutch pure play education content and services business; and UK-based Protocol, a recruitment agency focused on skills, education and training. Glendower Capital provided $100 million to Compass to fund this transaction.


HKW-backed GCR buys MB3

GCR, a portfolio company of Hammond, Kennedy, Whitney & Company Inc, has acquired Ottawa, Ontario-based MB3 Technologies Inc, a software development company focused on emergency grants management. No financial terms were disclosed. GCR is an international professional services firm based in New Orleans.


VC-backed Constellation Pharmaceuticals rolls out IPO

Cambridge, Massachusetts-based Constellation Pharmaceuticals Inc, a developer of tumor-targeted and immuno-oncology therapies, has raised $60 million for its IPO after pricing its 4 million shares at $15 per share. The stock began trading July 19, 2018 on the NASDAQ under the ticker symbol “CNST.” J.P. Morgan, Jefferies and BMO Capital Markets are the lead underwriters. The investors included Cormorant Asset Management, Deerfield Management, Fidelity Management and Research Company, Hillhouse Capital, NS Investment, OrbiMed, Sirona Capital, Venrock Healthcare Partners, The Column Group, Third Rock Ventures, Venrock, SROne, University of California Investment Office, Topspin Partners and Casdin Capital.